| Zacks Company Profile for LeMaitre Vascular, Inc. (LMAT : NSDQ) |
|
|
| |
| • Company Description |
| LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time.
Number of Employees: 488 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $43.41 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 182,988 shares |
| Shares Outstanding: 21.95 (millions) |
| Market Capitalization: $952.94 (millions) |
| Beta: 1.29 |
| 52 Week High: $64.50 |
| 52 Week Low: $38.32 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
-6.67% |
1.89% |
| 12 Week |
2.70% |
10.99% |
| Year To Date |
-13.58% |
2.36% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
63 SECOND AVENUE
-
BURLINGTON,MA 01803
USA |
ph: 781-221-2266
fax: 781-425-5049 |
None |
http://www.lemaitre.com |
|
|
| |
| • General Corporate Information |
Officers
George W. LeMaitre - Chief Executive Officer and Chairman of the Board
David B. Roberts - President and Director
Joseph P. Pellegrino - Chief Financial Officer
Lawrence J. Jasinski - Director
John J. O'Connor - Director
|
|
Peer Information
LeMaitre Vascular, Inc. (BJCT)
LeMaitre Vascular, Inc. (CADMQ)
LeMaitre Vascular, Inc. (APNO)
LeMaitre Vascular, Inc. (UPDC)
LeMaitre Vascular, Inc. (IMTIQ)
LeMaitre Vascular, Inc. (CYGN)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 525558201
SIC: 3841
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
|
|
Share - Related Items
Shares Outstanding: 21.95
Most Recent Split Date: (:1)
Beta: 1.29
Market Capitalization: $952.94 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 1.15% |
| Current Fiscal Quarter EPS Consensus Estimate: $0.32 |
Indicated Annual Dividend: $0.50 |
| Current Fiscal Year EPS Consensus Estimate: $1.25 |
Payout Ratio: 0.40 |
| Number of Estimates in the Fiscal Year Consensus: 3.00 |
Change In Payout Ratio: 0.05 |
| Estmated Long-Term EPS Growth Rate: 10.00% |
Last Dividend Paid: 03/07/2022 - $0.13 |
| Next EPS Report Date: 08/04/22 |
|
|
|
| |
